|Age:||18 years or older|
|Keywords:||hemophilia B, blood clotting disorder|
|Type:||Genetic study, Phase 3|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
150 previous exposure days of treatment with factor IX protein
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.